Invivo, officially known as Invivo Therapeutics, is a pioneering biotechnology company headquartered in France. Established in 2010, Invivo focuses on developing innovative solutions in the field of regenerative medicine, particularly for spinal cord injuries. With a strong presence in Europe and North America, the company has made significant strides in advancing its core products, including its unique biopolymer scaffolds designed to support nerve regeneration. Recognised for its commitment to scientific excellence, Invivo has achieved notable milestones, including successful preclinical trials and collaborations with leading research institutions. The company’s cutting-edge technologies position it as a leader in the regenerative medicine industry, aiming to transform the lives of patients with debilitating injuries.
How does Invivo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Invivo's score of 18 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Invivo reported total carbon emissions of approximately 347,527,000 kg CO2e, comprising about 246,792,000 kg CO2e from Scope 1 and about 100,735,000 kg CO2e from Scope 2. This marks a significant increase from 2022, where the total emissions were also about 347,527,000 kg CO2e, with the same breakdown for Scope 1 and Scope 2 emissions. For 2024, Invivo's emissions rose further to approximately 528,518,000 kg CO2e, with Scope 1 emissions at about 398,491,000 kg CO2e and Scope 2 emissions at about 130,027,000 kg CO2e. This upward trend highlights the challenges the company faces in managing its carbon footprint. Despite these figures, Invivo has not disclosed specific reduction targets or initiatives aimed at decreasing its emissions. The absence of defined climate pledges or targets suggests a need for enhanced commitment to sustainability practices within the organisation. As the company continues to navigate its environmental impact, it remains crucial for Invivo to establish clear strategies for emissions reduction in alignment with industry standards.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | 2024 | |
---|---|---|---|
Scope 1 | 246,792,000 | 000,000,000 | 000,000,000 |
Scope 2 | 100,735,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Invivo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.